phlorhizin has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, Z; Li, A; Li, Z; Wang, Z; Wu, H; Xie, Y; Xing, Z; Yang, Z; Zhang, X; Zhang, Z | 1 |
1 other study(ies) available for phlorhizin and Esophageal Neoplasms
| Article | Year |
|---|---|
Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway.
Topics: Autophagy; Camellia sinensis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Phlorhizin; Plant Extracts; Sequence Analysis, RNA; Signal Transduction; STAT3 Transcription Factor | 2021 |